DE-104 ophthalmic solution, medium concentration

DRUG2 trials

Sponsors

Santen Inc., Santen Pharmaceutical Co., Ltd.

Conditions

Ocular HypertensionOpen-Angle Glaucoma

Phase 2

Safety and Efficacy Study of DE-104 Ophthalmic Solution to Treat Open-angle Glaucoma or Ocular Hypertension

CompletedNCT00650338

Santen Inc.Ocular Hypertension, Open-Angle Glaucoma

Start: 2008-03-31End: 2008-10-31Target: 165Updated: 2011-11-03

Safety and Efficacy Study of DE-104 Ophthalmic Solution to Treat Open-Angle Glaucoma or Ocular Hypertension

CompletedNCT00657579

Santen Pharmaceutical Co., Ltd.Ocular Hypertension, Open-Angle Glaucoma

Updated: 2009-03-16